The bar chart illustrates the sales rate of a pharmaceutical company between 2002 and 2006 in America, Europe and Asia.
Overall, the sales were higher in America and Europe at the beginning of the periods investigated, while Asia buyers showed a consistant upward trend over the years.
The number of sales in America during 2002 peaked at 41%, compared to 34% in Europe and 25% in Asia. However, American and European sales experienced fluctuations across the years. In 2003, the drug company’s profit were 35% from America, slightly decreasing to 27% in 2004 and 29% in 2005. In 2006, America had 5% less sales than the same region in 2003.
Asia accounted for 34% in 2002, with a slight growth to 35% in 2003 and 38% in 2004, although this upward trend started too decay in 2005 and 2006 (34% and 30%, respectively). Furthermore, Asia represented 25% in 2005, rising 5% in 2003 and more 5% in 2004. In 2005, sales accounted for 37%, whereas in 2006 this number rose to 40%, the larger proportion compared to the other regions in the same year.
